Clinical trial

A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch Alterations

NCT02299635

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2015-02-03

PhasePHASE2

Study timeline

Study start (actual)2015-02-03Date precision: day

Registry last updated2019-01-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Triple Negative Breast Neoplasmsunresolved

Interventions

PF-03084014DRUG

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

BarcelonaSpain4 StanfordCalifornia, United States3 BostonMassachusetts, United States2 ChicagoIllinois, United States2 MadridSpain2 KrakowPoland2 New YorkNew York, United States1 LondonUnited Kingdom1 MilanItaly1 ValenciaSpain1 SevilleSpain1 PoznanPoland1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02299635 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.